AstraZeneca
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study
- Conditions
- Obsessive Compulsive Disorder
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2011-01-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 90
- Registration Number
- NCT00318539
- Locations
- 🇳🇱
Research Site, Utrecht, Netherlands
Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer
- Conditions
- Metastatic Breast Cancer
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2007-12-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 66
- Registration Number
- NCT00319618
- Locations
- 🇳🇴
Research Site, Oslo, Norway
PPI Test in GP Patients
- Conditions
- GERD
- First Posted Date
- 2006-04-26
- Last Posted Date
- 2007-08-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 100
- Registration Number
- NCT00318084
- Locations
- 🇳🇱
Research Site, Utrecht, Netherlands
Safety and Efficacy Study to Determine Anti-Asthmatic Effect of Esomeprazole Magnesium; Nexium Reflux Asthma
- First Posted Date
- 2006-04-24
- Last Posted Date
- 2014-06-09
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 961
- Registration Number
- NCT00317044
- Locations
- 🇨🇭
Research Site, Basel, Basel Stadt, Switzerland
Study of BMS-477118 as Monotherapy With Titration in Subjects With Type 2 Diabetes Who Are Not Controlled With Diet and Exercise
- First Posted Date
- 2006-04-20
- Last Posted Date
- 2015-04-29
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 365
- Registration Number
- NCT00316082
- Locations
- 🇺🇸
Southland Clinical Research Center, Inc., Fountain Valley, California, United States
🇺🇸Winston Technology, Inc., Haleyville, Alabama, United States
🇺🇸Clinical Reseacrh Advantage/ Brown Family Medicine, Mesa, Arizona, United States
Phase I Study of ZD4054 (Zibotentan) and Docetaxel in Patients With Metastatic HRPC
- Conditions
- Prostate Cancer
- Interventions
- First Posted Date
- 2006-04-17
- Last Posted Date
- 2013-03-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 44
- Registration Number
- NCT00314782
- Locations
- 🇬🇧
Research Site, Surrey, United Kingdom
Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506)
- Conditions
- Asthma
- First Posted Date
- 2006-04-14
- Last Posted Date
- 2016-12-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 240
- Registration Number
- NCT00314509
- Locations
- 🇿🇦
Altana Pharma/Nycomed, Pretoria, South Africa
Quetiapine Fumarate Bipolar Maintenance Monotherapy
- Conditions
- Bipolar Disorder
- First Posted Date
- 2006-04-13
- Last Posted Date
- 2008-12-22
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1255
- Registration Number
- NCT00314184
- Locations
- 🇺🇦
Research Site, Vinnitsa, Ukraine
Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.
- Conditions
- Anxiety Disorders
- First Posted Date
- 2006-04-13
- Last Posted Date
- 2009-03-25
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 575
- Registration Number
- NCT00314210
- Locations
- 🇬🇧
Research Site, Manchester, United Kingdom
🇺🇸Research SIte, Middleburg Heights, Ohio, United States
A Clinical Trial to Compare Efficacy and Tolerability of Fulvestrant 250mg, 250mg Plus 250mg Loading Regimen and 500mg
- Conditions
- Advanced Breast CancerMetastatic Breast Cancer
- Interventions
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2020-01-06
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 144
- Registration Number
- NCT00313170
- Locations
- 🇹🇷
Research Site, Istanbul, Turkey